Probiotics can improve the clinical outcomes of hepatic encephalopathy: An update meta-analysis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinics And Research in Hepatology and Gastroenterology

• Publication date

  2015-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clinre.2015.03.008PMID 25956487
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis

  2014cited by this paper
• Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.

  2014cited by this paper
• Management of hepatic encephalopathy in the hospital.

  2014cited by this paper
• The role of microbiota in hepatic encephalopathy

  2014cited by this paper
• Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).

  2014cited by this paper
• Effect of Rifaximin, Probiotics, and l-Ornithine l-Aspartate on Minimal Hepatic Encephalopathy: A Randomized Controlled Trial

  2014cited by this paper
• A randomized-controlled trial to compare the effect of lactulose and probiotics on treatment of minimal hepatic encephalopathy

  2013cited by this paper
• Combination Therapy for the Treatment and Prevention of Hepatic Encephalopathy

  2012cited by this paper
• Systematic review and meta‐analysis of randomized trials on probiotics for hepatic encephalopathy

  2012cited by this paper
• In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009.

  2012cited by this paper
• Efficacy Analysis on Treatment of Subclinical Hepatic Encephalopathy by Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules

  2012cited by this paper
• A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy.

  2011cited by this paper
• Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study.

  2011cited by this paper
• Probiotics for patients with hepatic encephalopathy.

  2011cited by this paper
• A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy

  2011cited by this paper
• Observation on the efficacy of Lactulose and Probiotics in preventing hepatic encephalopathy

  2011cited by this paper
• Meta‐analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy

  2011cited by this paper
• Clinical Researches of Bifid Triple Viable on the Treatment of Subclinical Hepatic Encephalopathy

  2010cited by this paper
• Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis: An Open-Label, Randomized Controlled Trial of Lactulose, Probiotics, and No Therapy

  2010cited by this paper
• Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy

  2010cited by this paper
• Minimal hepatic encephalopathy is associated with motor vehicle crashes: The reality beyond the driving test

  2009cited by this paper
• An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy

  2008cited by this paper
• Minimal hepatic encephalopathy matters in daily life.

  2008cited by this paper
• Probiotic Yogurt for the Treatment of Minimal Hepatic Encephalopathy

  2008cited by this paper
• Curative Effects of Bacillus Licheniformis Capsule on Course of Subclinical Hepatic Encephalopathy

  2008cited by this paper
• Bifidobacterium longum with Fructo-Oligosaccharide (FOS) Treatment in Minimal Hepatic Encephalopathy: A Randomized, Double-Blind, Placebo-Controlled Study

  2007cited by this paper
• Effects of probiotics agents treatment on the couse of subclincal hepatic encephalopathy

  2006cited by this paper
• [Effect of administration of Escherichia coli Nissle (Mutaflor) on intestinal colonisation, endo-toxemia, liver function and minimal hepatic encephalopathy in patients with liver cirrhosis].

  2006cited by this paper
• Study of Ganciclovir and SNMC on treating children with infections mononucleosis

  2006cited by this paper
• Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis

  2004cited by this paper
• Minimal hepatic encephalopathy impairs fitness to drive

  2004cited by this paper
• Quality of Life in Cirrhotics with Minimal Hepatic Encephalopathy

  2001cited by this paper
• Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.

  1999cited by this paper
• Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM Statement

  1999cited by this paper
• Enterococcus Lactic Acid Bacteria Strain SF68 and Lactulose in Hepatic Encephalopathy: A Controlled Study

  1987cited by this paper

• Hepatic encephalopathy in cirrhosis: therapies and developments

  2025cites this paper
• Probiotics for the Management of Liver Cirrhosis and Its Complications.

  2025cites this paper
• Nontraditional Treatment of Hepatic Encephalopathy.

  2024cites this paper
• Chronic Liver Disease and Promising Therapeutic Strategy: A Concise Review

  2024cites this paper
• Probiotics/prebiotics/synbiotics and human neuropsychiatric outcomes: an umbrella review.

  2024cites this paper
• Impacts of gut microbiota alteration on age-related chronic liver diseases.

  2023cites this paper
• Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis

  2023cites this paper
• Research Progress in Traditional Chinese and Western Medicine for Hepatic Encephalopathy

  2023cites this paper
• Gut Microbiome and Organ Fibrosis

  2022cites this paper
• Hepatic encephalopathy and strategies to prevent readmission from inadequate transitions of care.

  2022cites this paper
• The gut microbiota in hepatic encephalopathy

  2021cites this paper
• Minimal hepatic encephalopathy – diagnosis and treatment

  2021cites this paper
• Microbiome Therapeutics for Hepatic Encephalopathy.

  2021cites this paper
• Gut microbial profiling as a therapeutic and diagnostic target for managing primary biliary cholangitis.

  2020cites this paper
• Childhood functional gastrointestinal disorders: rational therapy

  2020cites this paper
• Probiotics and prebiotics

  2020cites this paper
• Nonpharmacologic Management of Hepatic Encephalopathy: An Update.

  2020cites this paper
• Pharmacologic Management of Hepatic Encephalopathy.

  2020cites this paper
• Role of gut microbiota via the gut-liver-brain axis in digestive diseases

  2020cites this paper
• Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review & Network Meta-analysis.

  2020cites this paper
• Hepatic Encephalopathy and Sarcopenia: Two Faces of the Same Metabolic Alteration.

  2019influential citation
• Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis

  2019cites this paper
• Hepatic Encephalopathy Challenges, Burden, and Diagnostic and Therapeutic Approach.

  2019cites this paper
• Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in d-galactosamine-treated rats

  2018cites this paper
• Chapter 105 – Prescribing Probiotics

  2018cites this paper
• Pathophysiology: Gut Liver Axis Changes

  2018cites this paper
• Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease

  2018influential citation
• Gut microbiata: underestimated or exaggerated?

  2018cites this paper
• Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy.

  2018cites this paper
• Probiotics for people with hepatic encephalopathy.

  2017cites this paper
• Probiotic guidelines and physician practice: a cross-sectional survey and overview of the literature.

  2017cites this paper
• The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy: A Systematic Review

  2017cites this paper
• Recent advances in hepatic encephalopathy

  2017cites this paper
• Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction

  2017cites this paper
• article : the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease

  2017influential citation
• Hepatic encephalopathy: a critical current review

  2017cites this paper
• Probiotics are helpful in hepatic encephalopathy: a meta‐analysis of randomized trials

  2016cites this paper
• Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions

  2016cites this paper
• World Journal of Gastroenterology

  year unknowncites this paper